Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Allmed products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Healthcare and pharmaceutical company · Lahore · Pakistan

Karachi healthcare group active in pharmaceuticals, medical equipment and diagnostics, with a specialized renal-care pharmaceutical portfolio.

Allmed products in Pakistan

Allmed (Pvt.) Ltd has 82 medicine presentations registered in Pakistan under 47 brands, covering 48 generic medicines. Most of its products are in Anti-infectives, Vitamins, minerals & nutrition and Respiratory & allergy. Its brands with the most registered strengths and packs are A-CIP (Ciprofloxacin), LEVOGREEN (Levofloxacin), SALBUGREEN (Salbutamol) and ANOMED (Ondansetron). 82 products have an official DRAP price on MedInfoBase. See all 47 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation13 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date20 Aug 2026Newest effective date among published current price records
Corporate profile evidence6 sourcesCorporate source details checked 21 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Allmed (Pvt.) Ltd.
Company type
Healthcare and pharmaceutical company
Address
Plot No. 590, Sundar Industrial Estate, Lahore, Pakistan · 74800
Phone
+92 21 34943800
Official contact
Contact page ↗
Corporate source details checked
21 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000645 Allmed (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000645 82 linked products · source seen 13 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx93public portfolio records represented
REG86unique registrations represented
IDX0indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER52registry-verified exact registrations
PKR82current validated price records
G48generic molecules in indexed catalogue
DF8dosage-form groups
TA10therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage88%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage98%
priced packs safely normalized per unit
Comparable-market coverage84%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixAllmed (Pvt.) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 13 Nov 2026Anti-infectives43 · 52%Vitamins, minerals & nutrition9 · 11%Respiratory & allergy8 · 10%Gastrointestinal & hepatology6 · 7%Pain & musculoskeletal5 · 6%Hematology & thrombosis3 · 4%Fluids & supportive care2 · 2%Other therapeutic areas6 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioAllmed (Pvt.) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 13 Nov 202682presentationsTablet39 · 48%Capsule11 · 13%Injection10 · 12%Syrup10 · 12%Infusion8 · 10%Inhalation2 · 2%Other forms2 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionAllmed (Pvt.) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 13 Nov 202669comparable productsBelow peer median20 · 29%Near peer median20 · 29%Above peer median29 · 42%Company median price position+3.5%Lowest-price equivalents7Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsAllmed (Pvt.) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/allmed-pvt-ltdGenerated 13 Nov 2026Mediate Pharmaceutical Pvt Ltd29 shared60% overlapSAMI Pharmaceuticals Pvt. Ltd.29 shared60% overlapEpharm Laboratories29 shared60% overlapBosch Pharmaceuticals (Pvt) Ltd.28 shared58% overlapBio-Labs(Pvt) Ltd28 shared58% overlapShaigan Pharmaceuticals (Pvt) Ltd28 shared58% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet39 products
Capsule11 products
Injection10 products
Syrup10 products
Infusion8 products
Inhalation2 products
Solution1 products
Suspension1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Allmed (Pvt.) Ltd is priced against the market

69 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers75Distinct registrations among indexed, published, presentation-validated products only
Verified price observations153
Products with a verified price82
Products with multiple price observations71
Source records with multiple versions82
Latest portfolio source check22 Sep 2026
Latest effective price date20 Aug 2026
Latest source observation13 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

86 unique registration(s) · 0 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
No matching products.
A to Z

All 47 Allmed brands in Pakistan

  • A-CIP Ciprofloxacin · 200 mg/100 mL infusion, 250 mg tablet, 400 mg/100 mL infusion
  • ANEMFER Iron protein succinylate, Iron · 50 mg/15 mL syrup, 50 mg/5 mL syrup
  • ANOMED Ondansetron · 4 mg/5 mL solution, 8 mg tablet, 8 mg injection
  • AQUAGREENINJECTION Water for Injection · 5 mg injection, 5 mL injection
  • B-FIX Lamivudine · 100 mg tablet
  • BANAKE Paracetamol + Orphenadrine · 450 mg + 35 mg tablet
  • C-TX Valganciclovir · 450 mg tablet
  • CALSO Elemental Calcium · 667 mg tablet
  • CARBOFER Iron · 20 mg/mL injection
  • CKAR Ascorbic acid · 500 mg tablet
  • CLAMY-250 Clarithromycin · 250 mg tablet
  • CLAMY-500 Clarithromycin · 500 mg tablet
  • DEFOX Deferasirox · 100 mg tablet
  • DIREARID Loperamide HCl · 2 mg capsule
  • Dymzol Clotrimazole · 500 mg tablet
  • EVERFEN Ibuprofen · 100 mg/5 mL syrup
  • EVERLOSE Lactulose · 3.35 mg/5 mL syrup
  • Everpol Paracetamol · 1 g/100 mL infusion, 500 mg tablet
  • FAROZEN Citirizine 2HCl, Cetirizine · 10 mg tablet
  • FOFY Fosfomycin · 500 mg capsule
  • HEMFIL Iron, Iron polymaltose complex · 50 mg/5 mL syrup
  • HEMFIL-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet
  • Isoflo Isoflurane · 100% inhalation
  • ITRDYM Itraconazole · 100 mg capsule
  • Ivoryzone Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
  • IZITHOL Azithromycin · 250 mg capsule, 500 mg tablet
  • LEVOGREEN Levofloxacin · 250 mg tablet, 250 mg/100 mL infusion, 500 mg tablet
  • LOLERGY Loratadine · 10 mg tablet, 5 mg/5 mL syrup
  • LOMAR Artemether + Lumefantrine, Artemether · 20 mg + 120 mg tablet, 40 mg + 240 mg tablet, 80 mg/mL injection
  • LORITA Lopinavir + Ritonavir · 200 mg + 50 mg tablet
  • Maxon Moxifloxacin · 400 mg tablet, 400 mg/250 mL infusion
  • METGLAV Vildagliptin · 50 mg tablet
  • METLA Metronidazole · 200 mg/5 mL syrup, 400 mg tablet, 500 mg/100 mL infusion
  • OKSIN Ofloxacin · 200 mg tablet, 200 mg/100 mL infusion
  • PROCED Omeprazole · 20 mg capsule
  • QUINGEN Chloroquine · 250 mg tablet, 50 mg/5 mL syrup
  • QUINGEN-H Hydroxychloroquine · 200 mg tablet
  • RUTEX Cefixime · 100 mg/5 mL suspension, 400 mg capsule
  • SALBUGREEN Salbutamol · 0.5 mg/mL injection, 2 mg tablet, 2 mg/5 mL syrup
  • Sevoflo Sevoflurane · 100% inhalation
  • TACOGEN Tacrolimus · 1 mg capsule
  • TAMAVIR Oseltamivir · 75 mg capsule
  • TRANSAGER Tranexamic acid · 250 mg injection, 500 mg capsule
  • VIRLIL Ribavirin · 400 mg capsule, 600 mg tablet
  • VIVAX Artesunate · 100 mg tablet, 50 mg tablet
  • ZOLDI Fluconazole · 50 mg capsule
  • ZOMED Letrozole · 2.5 mg tablet
Questions

Allmed: common questions

How many products does Allmed have in Pakistan?

Allmed (Pvt.) Ltd has 82 registered medicine presentations in Pakistan, sold under 47 brands and covering 48 generic medicines.

What are the main brands of Allmed?

By number of registered strengths and packs, its largest brands are A-CIP (Ciprofloxacin), LEVOGREEN (Levofloxacin), SALBUGREEN (Salbutamol), ANOMED (Ondansetron) and Everpol (Paracetamol). This is not a sales ranking.

Which therapy areas does Allmed cover?

The most products are in Anti-infectives (43), Vitamins, minerals & nutrition (9), Respiratory & allergy (8), Gastrointestinal & hepatology (6) and Pain & musculoskeletal (5).

Where can I see Allmed medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Allmed (Pvt.) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 13, 2026, from https://medinfobase.com/company/allmed-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9